3.0.0 2026 2023-01-11T13:36:01Z 2023-01-11T13:36:01Z House HR 2017-04-06 115 [Congressional Record Volume 163, Number 60 (Thursday, April 6, 2017)]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. GUTHRIE:H.R. 2026.Congress has the power to enact this legislation pursuantto the following:Article 1 Section 8 of the United States Constitution[Page H2791]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Reported by 2018-01-17T17:50:24Z Markup by 2018-01-17T17:49:21Z Referred to 2017-04-07T14:49:38Z Referred to 2017-04-06T13:16:10Z 2018-01-17 hsif14 Health Subcommittee 1 House committee actions Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 14 . Committee 2018-01-17 hsif14 Health Subcommittee 1 House committee actions Subcommittee Consideration and Mark-up Session Held. Committee 2017-04-07 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2017-04-06 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2017-04-06 Introduced in House IntroReferral Intro-H 9 Library of Congress 2017-04-06 Introduced in House IntroReferral 1000 9 Library of Congress G000558 Rep. Guthrie, Brett [R-KY-2] Brett Guthrie R KY 2 N Health Drug safety, medical device, and laboratory regulation Fraud offenses and financial crimes Health information and medical records Medical research Health 00 2017-04-06 Introduced in House 2017-12-19T22:45:26Z Pharmaceutical Information Exchange Act

This bill amends the Federal Food, Drug, and Cosmetic Act to allow information about a new investigational medication or the investigational use of a medication approved by the Food and Drug Administration to be provided to health care entities if the information is based on reliable scientific evidence.

]]> Pharmaceutical Information Exchange Act Display Title Pharmaceutical Information Exchange Act Official Title as Introduced To improve patient access to emerging medication therapies by clarifying the scope of permitted health care economic and scientific information communications between biopharmaceutical manufacturers and population health decision makers. Introduced in House IH Short Titles as Introduced Pharmaceutical Information Exchange Act Introduced in House 2017-04-06T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-115hr2026ih/xml/BILLS-115hr2026ih.xml 2018-01-17 Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 14 . text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.